On ECHEMI
Home > Drugs > Rifaximin Registered Holders
Rifaximin structure

Rifaximin structure

Rifaximin

Rifaximin(Xifaxan) is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity.IC50 Value:Target: RNA polymerase; antibacterialRifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It is used in the treatment of traveler's diarrhea and hepatic encephalopat

Find 37 Related Holders

OLON S.p.A.
Japan Japan

API Registration Country

API Active
SOLARA ACTIVE PHARMA SCIENCES LTD
United States United States

API Registration Country

API Active
ZHEJIANG MEDICINE CO LTD
United States United States

API Registration Country

API Active
Granules India Ltd
United States United States

API Registration Country

API Inactive
PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTD
United States United States

API Registration Country

API Inactive
LUPIN LTD
United Kingdom United Kingdom

API Registration Country

API Inactive
  • Founded in:

    2021-11-29 00:00:00
  • Country:

    United Kingdom United Kingdom
  • Address:

    85 Great Portland Street, First Floor, London, England, W1W 7LT
Yangzhou NO.3 Pharmacitical Manufacture Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    2000-12-28
  • Country:

    China China
  • Address:

    No. 51, Guotai Road, Yiling Town, Jiangdu District, Yangzhou City
  • Tax NO.:

    91321012717489085N
  • Registered Funds:

    7.796697 yuan
  • Website:

  • Email:

Recommended Suppliers of Rifaximin
View 81 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.